GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SUVH5 sra bound to fully hydroxymethylated cg DNA

Analyse Crystal structure of SUVH5 sra bound to fully hydroxymethylated cg DNA in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4YGI
Type
protein + DNA
Length
160 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH5; Polydeoxyribonucleotide
EC
2.1.1.43
UniProt
O82175
Ligands
MG
Pockets
3 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase, H3 lysine-9 specific SUVH5 (EC 2.1.1.43)protein15012% helix, 34% strandO82175
BPolydeoxyribonucleotidedna10——

Ligands and binding sites

  • MG · Magnesium ion · metal · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.460.8318empty
2710.330.7614empty
3640.270.7319empty

Interfaces

1 interface between chains.

  • A–B · 592 Ų buried · 16 hydrogen bonds · protein-nucleic

Modifications

Observed in the structure: 1 modified (nucleotide modification).

Compared structures

  • 4YGI · Crystal Structure of SUVH5 SRA bound to fully hydroxymethylated CG DNA · the same entry in another collection · chain A against A, TM-score 1.00
  • O82175 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase, H3 lysine-9… · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.